Ibogaine Treatment Cleveland, OH: Cost, Legality, Clinics

Ibogaine Treatment Cleveland, Ohio: Vetted Clinics for Cuyahoga County Patients

Ohio is one of a small number of states now formally studying ibogaine — the legislature seated an Ibogaine Treatment Study Committee in December 2025. Studying a medicine and permitting it are different things, and Ohio has done only the first. No clinic in Cleveland can administer ibogaine today.

Ibogaine is a Schedule I substance under federal law and Ohio has created no exemption. For Cuyahoga County patients who need treatment now, the path leads to licensed, medically supervised clinics in Mexico.

Psychedelic Connect is a treatment advisory service. We connect Cleveland and Northeast Ohio patients with vetted ibogaine clinics in Mexico. Call (866) 435-7057 or request a consultation to speak with a patient coordinator.

For a full picture of what to budget, see what ibogaine treatment costs.

Can You Get Ibogaine Treatment in Cleveland?

No. Ibogaine is Schedule I federally and there is no licensed ibogaine clinic in Ohio. The state has a legislative study committee examining it, but that committee cannot authorise treatment. Legal, medically supervised care means travelling to Mexico.

If a Cleveland-area provider advertises ibogaine, that is a reason for concern rather than convenience. Unsupervised ibogaine is genuinely dangerous — it affects cardiac rhythm, and the deaths associated with it have overwhelmingly occurred outside medical settings, without screening or monitoring.

What Is Ohio’s Ibogaine Study Committee?

A legislative committee created in the FY2026-27 state operating budget (H.B. 96), chaired by Rep. Justin Pizzulli. It is evaluating ibogaine for substance use disorders and for veterans with PTSD, depression and mild traumatic brain injury. It first met in December 2025.

The committee met again at the Ohio Statehouse on 6 May 2026. Its work is evaluative: it is expected to give lawmakers recommendations on whether Ohio should allow or encourage clinical use of ibogaine.

What that means for you, plainly: there is no Ohio programme to enrol in, no waiting list, and no timetable that has been made public for legal access. A study committee is the earliest stage of a long process. Anyone who tells a Cleveland patient they can be placed in an Ohio ibogaine programme is describing something that does not exist.

Sources: Ohio House of Representatives release, 15 December 2025; Ibogaine Treatment Study Committee meeting notice, 6 May 2026.

Does Ibogaine Fit Cleveland’s Actual Overdose Picture?

Partly — and this is where we will give you a straighter answer than most. Ibogaine’s strongest evidence is in opioid dependence. Cuyahoga County’s overdose profile has shifted toward cocaine, where the evidence for ibogaine is much thinner.

The Cuyahoga County Medical Examiner’s Office recorded 276 fentanyl overdose deaths in 2024 and 140 in 2025 — roughly half. Dr. Thomas Gilson, the county medical examiner, has described cocaine as now the leading drug in local overdose deaths. The county publishes this data publicly, with a dashboard developed with the Begun Center for Violence Prevention Research and Education at Case Western Reserve University — one of the better local overdose data operations in the country.

That matters for anyone considering ibogaine:

• For opioid dependence — fentanyl, heroin, prescription opioids, methadone and buprenorphine — ibogaine has the most support, principally its capacity to interrupt withdrawal. See ibogaine for opioid dependence.
• For cocaine and stimulant dependence, the published evidence is considerably weaker. There is no withdrawal syndrome for ibogaine to interrupt in the same way, and the case reports are fewer and less consistent.
• For alcohol, evidence exists but detox must be medically managed first, because alcohol withdrawal itself can be dangerous.

We would rather tell a Cleveland family that ibogaine is a poor fit for their situation than take an enquiry we cannot honestly serve.

What Does the Evidence Actually Show?

Promising and consistent across small studies, but not yet proven to a regulator’s standard. The best-known ibogaine result comes from an observational study of 30 veterans with no control group — striking, but not a randomised trial.

The most-cited study is Cherian et al. (Nature Medicine, 2024), which followed 30 special operations veterans with traumatic brain injury who received ibogaine at a clinic in Mexico and reported large reductions in PTSD, depression and anxiety symptoms. It is a genuinely striking result — and it was observational, with 30 participants and no control group. It is not a randomised trial, and it should not be read as one.

That is the honest position: promising, consistently so across small studies, and not yet proven to the standard a regulator requires. Ohio’s own committee exists precisely because that gap has not been closed.

Getting from Cleveland to a Mexican Clinic

Most Northeast Ohio patients fly from Cleveland Hopkins International Airport (CLE) to Cancún, where the largest concentration of established ibogaine clinics sits, or to Tijuana for Baja California facilities. Nonstop service to Cancún from CLE is seasonal and changes year to year, so plan on a connection unless current schedules say otherwise — we check routing with you as part of the planning.

Travel time is the least important variable. Programme length, whether a physician is on site overnight, what cardiac and liver screening is required before you fly, and whether integration is included matter far more to the outcome than a connection.

What Happens Before You Travel?

Screening comes first. Ibogaine affects heart rhythm, so clinics require an ECG and bloodwork, a full medication review and a medical history before accepting anyone. Some people are screened out — and being told no is the system working.

• Initial conversation — what you are treating, what you have tried, current medications and doses.
• Medical screening — ECG, liver and kidney panels, electrolytes. Some medications, particularly certain antidepressants and long-acting opioids, need a supervised taper well beforehand.
• Clinic matching — facilities whose medical model fits the presentation, not whichever has a bed.
• Treatment — most programmes run seven to ten days.
• Integration — the part that determines whether the result holds. See integration therapy after ibogaine.

If you are in acute withdrawal or crisis right now, call 988 or 911. Ibogaine requires preparation and cannot be accessed on an emergency timeline.

What Does Treatment Cost for Ohio Patients?

Between $5,000 and $15,000, depending on length of stay and facility. Insurance does not cover it, because ibogaine is Schedule I in the United States. Budget separately for flights from Cleveland and for integration support afterwards.

The range reflects real differences: programme length, whether a physician is on site around the clock, the level of cardiac monitoring, private versus shared accommodation, and whether integration is bundled. A very low price usually means fewer medical staff, which is the wrong place to economise.

What Psychedelic Connect Does

We are a treatment advisory service, not a clinic. We do not administer ibogaine and we do not own a facility. We help you work out whether ibogaine is reasonable in your specific case, and if it is, which clinic fits.

We visit the clinics we recommend — we look at medical staffing, monitoring equipment, what happens overnight, and what the facility does when something goes wrong. We are guided by people who get it, including clinicians and people who have been through this themselves. Our clinical content is reviewed by Christopher Diviaio, LCSW.

Resources in Cleveland and Cuyahoga County:

• SAMHSA National Helpline: (800) 662-4357 — 24/7 treatment referral (samhsa.gov)
• 988 Suicide & Crisis Lifeline: call or text 988
• Veterans Crisis Line: 988, then Press 1
• Cuyahoga County ADAMHS Board 24/7 crisis line: (216) 623-6888

Consultation — Call Today

If you are in Cleveland, Lakewood, Parma, Akron or anywhere in Northeast Ohio, call (866) 435-7057 to talk with a patient coordinator. You can also start with our online form and we will follow up within one business day.

Medical Disclaimer: Psychedelic Connect is a treatment advisory service. We do not provide medical advice. Ibogaine treatment involves serious medical considerations including cardiac risks. Always consult a qualified medical professional before pursuing any treatment.

Frequently Asked Questions — Ibogaine Treatment, Cleveland and Ohio

Is ibogaine legal in Ohio?
No. Ibogaine is a Schedule I controlled substance under federal law and Ohio has not created a state exemption. Possession is illegal and no Ohio clinic can administer it. The state has seated a legislative study committee, but a study committee does not create legal access. See where ibogaine is legal in 2026.

Will Ohio legalise ibogaine treatment?
Nobody can say. The Ibogaine Treatment Study Committee, created in H.B. 96 and chaired by Rep. Justin Pizzulli, is evaluating ibogaine for substance use disorders and for veterans with PTSD, depression and mild TBI. Its role is to recommend, not to authorise. Treat any specific date you are given for Ohio legalisation as speculation.

Does ibogaine work for cocaine addiction?
The evidence is much weaker than for opioids, and this matters in Cuyahoga County, where cocaine has become the leading drug in overdose deaths. Ibogaine’s best-documented effect is interrupting opioid withdrawal, and there is no equivalent stimulant withdrawal for it to interrupt. We will tell you if we think it is a poor fit rather than place you anyway.

Are there programmes for Ohio veterans?
Yes. Several clinics in our network run protocols built around combat-related PTSD, TBI and co-occurring substance use, and some pair ibogaine with 5-MeO-DMT for trauma processing. Veterans are also the population Ohio’s own study committee is examining most closely. See ibogaine for veterans.

How dangerous is ibogaine?
It carries real cardiac risk, which is why legitimate clinics require an ECG and bloodwork beforehand and why a facility without a physician on site should be ruled out. Most reported deaths have occurred outside medical settings or where screening was skipped. See ibogaine side effects and risks. Anyone who tells you the risk is negligible is overselling it.

Psychedelic Connect · (866) 435-7057 · contact@psychedelic-connect.com

Published 11 September 2026 · Last updated 11 September 2026 · Clinical review: Christopher Diviaio, LCSW